Connecting IVR & Drug Supply
Trident: New Web Rand System
Ed Tourtellotte says slow, customized randomization is holding back the industry.
The integration of electronic data capture (EDC) with interactive voice response (IVR) systems to randomize patients is a natural one, and not routinely managed in a seamless manner. Two Florida firms are trying to make that easier. Late last year, OmniComm Systems, the small, publicly traded EDC firm, and IVR…more...
The modern clinical trial is built around a 2,000-year tool invented by the Chinese. Paper. Case report forms. Signatures. Binders of paper. Trucks filled with paper. FDA warehouses trembling under the heft of it. Some industries might be ashamed. Not ours. In the life sciences, every self-respecting company can talk…more...
The most notable nugget from the Center for Business Intelligence’s (CBI) Arlington, Virginia meeting on patient-reported outcome (PRO) research late last month was not so much from the podium, though there was plenty of excellent material there. Some of the most interesting news was in the questions from attendees. Your…more...
Once you do anything 500 times, you know how to do it. The contract research organization ICON has a group dedicated to interactive voice response (IVR), and they’ve completed their 650th trial. Only a fifth of its projects come via the parent company’s traditional CRO services group; the remaining eighty…more...
At the end of this month, in Arlington, Virginia, ClinPage will be attending the inaugural Patient Reported Outcome (PRO) conference, sponsored by the Center for Business Intelligence. We’ve long felt the convergence of technological change and regulatory acceptance of PRO warranted a meeting. We can’t wait to attend. One of…more...
The recent annual meeting of the Society for Clinical Data Management (SCDM) had its first annual “Data Driven Innovation” award. The inaugural prize was presented to Sirion Therapeutics and clinical technology suite supplier DSG of Philadelphia. It’s worth noting something from the SCDM is not just another trade show gimmick,…more...
Clinical data standards seem wonderful in the abstract. On a white board, the work of CDISC and HL7 should make life easier, cheaper and faster for everyone involved in any clinical trial, just as broccoli should be good for anybody’s health. Thinking about buying broccoli is more common than buying…more...
It’s not exactly a news flash that there are major problems with paper patient diaries in clinical trials. Let’s just take two massively important problems: Patients don’t fill out paper diaries when they say they do. And there’s no need to puzzle out something scrawled in another language, because the…more...
invivodata is one of a select number of firms—along with Arrowhead, CRF, PHT, and Symfo—specializing in handheld electronic diaries to record patient experiences in clinical trials. At the 2007 annual Drug Information Association (DIA) meeting, ClinPage chatted with invivodata founders Saul Shiffman and Jean Paty. Shiffman’s additional titles include chief…more...
Specialty pharma Cobalis will delay reporting trial results because of concerns about the quality of data from electronic patient diaries. Cobalis’s two similar Phase III allergy trials had a total of 1,551 patients and 23 sites. Here’s a quote from the press release: “Given inconsistencies it has identified, the company…more...
December 3, 2008
Ed Tourtellotte says slow, customized randomization is holding back the industry.
Two top firms, each specializing in different approaches to gathering patient experiences, will partner to help sponsors find the right technology.
At a user meeting later this month, invivodata will unveil a new device from a company other than Palm.
Using a tablet PC and the Apple phone, assiTek says larger screens can be helpful to science and sites.
Almac Clinical Technologies is adding electronic data capture to its expedited service offering.
A top technology supplier discusses the merits of combining two vital tools in a robust manner.
Organizations
Conferences
Info & Opinion